279 related articles for article (PubMed ID: 18495791)
1. Large volume "mammotome" biopsy may reduce the need for diagnostic surgery in papillary lesions of the breast.
Carder PJ; Khan T; Burrows P; Sharma N
J Clin Pathol; 2008 Aug; 61(8):928-33. PubMed ID: 18495791
[TBL] [Abstract][Full Text] [Related]
2. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
Carder PJ; Garvican J; Haigh I; Liston JC
Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
[TBL] [Abstract][Full Text] [Related]
3. Vacuum assisted stereotactic guided mammotome biopsies in the management of screen detected microcalcifications: experience of a large breast screening centre.
Kumaroswamy V; Liston J; Shaaban AM
J Clin Pathol; 2008 Jun; 61(6):766-9. PubMed ID: 18326021
[TBL] [Abstract][Full Text] [Related]
4. Conservative management of screen-detected radial scars: role of mammotome excision.
Rajan S; Wason AM; Carder PJ
J Clin Pathol; 2011 Jan; 64(1):65-8. PubMed ID: 21097791
[TBL] [Abstract][Full Text] [Related]
5. Imaging-guided core needle biopsy of papillary lesions of the breast.
Rosen EL; Bentley RC; Baker JA; Soo MS
AJR Am J Roentgenol; 2002 Nov; 179(5):1185-92. PubMed ID: 12388496
[TBL] [Abstract][Full Text] [Related]
6. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy.
Sydnor MK; Wilson JD; Hijaz TA; Massey HD; Shaw de Paredes ES
Radiology; 2007 Jan; 242(1):58-62. PubMed ID: 17090707
[TBL] [Abstract][Full Text] [Related]
7. Histological evaluation of papillary lesions of the breast from needle biopsy to the excised specimen: a single institutional experience.
Gilani S; Tashjian R; Kowalski P
Pathologica; 2013 Apr; 105(2):51-5. PubMed ID: 23946981
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous large-core biopsy of papillary breast lesions.
Liberman L; Bracero N; Vuolo MA; Dershaw DD; Morris EA; Abramson AF; Rosen PP
AJR Am J Roentgenol; 1999 Feb; 172(2):331-7. PubMed ID: 9930777
[TBL] [Abstract][Full Text] [Related]
9. Management of Clinically and Mammographically Occult Benign Papillary Lesions Diagnosed at Ultrasound-Guided 14-Gauge Breast Core Needle Biopsy.
Moon SM; Jung HK; Ko KH; Kim Y; Lee KS
J Ultrasound Med; 2016 Nov; 35(11):2325-2332. PubMed ID: 27629753
[TBL] [Abstract][Full Text] [Related]
10. Will the spectrum of lesions prompting a "B3" breast core biopsy increase the benign biopsy rate?
Carder PJ; Liston JC
J Clin Pathol; 2003 Feb; 56(2):133-8. PubMed ID: 12560393
[TBL] [Abstract][Full Text] [Related]
11. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
Rakha EA; Lee AH; Jenkins JA; Murphy AE; Hamilton LJ; Ellis IO
Int J Cancer; 2011 Sep; 129(6):1417-24. PubMed ID: 21128240
[TBL] [Abstract][Full Text] [Related]
12. Management of breast papillary lesions diagnosed in ultrasound-guided vacuum-assisted and core needle biopsies.
Yamaguchi R; Tanaka M; Tse GM; Yamaguchi M; Terasaki H; Hirai Y; Nonaka Y; Morita M; Yokoyama T; Kanomata N; Naito Y; Akiba J; Yano H
Histopathology; 2015 Mar; 66(4):565-76. PubMed ID: 25040190
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
El-Sayed ME; Rakha EA; Reed J; Lee AH; Evans AJ; Ellis IO
Histopathology; 2008 Dec; 53(6):650-7. PubMed ID: 19076681
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy.
Dillon MF; McDermott EW; Hill AD; O'Doherty A; O'Higgins N; Quinn CM
Ann Surg Oncol; 2007 Feb; 14(2):704-11. PubMed ID: 17151788
[TBL] [Abstract][Full Text] [Related]
15. Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience.
Hayes BD; O'Doherty A; Quinn CM
J Clin Pathol; 2009 Dec; 62(12):1136-40. PubMed ID: 19946101
[TBL] [Abstract][Full Text] [Related]
16. Significance of papillary lesions at percutaneous breast biopsy.
Valdes EK; Tartter PI; Genelus-Dominique E; Guilbaud DA; Rosenbaum-Smith S; Estabrook A
Ann Surg Oncol; 2006 Apr; 13(4):480-2. PubMed ID: 16474908
[TBL] [Abstract][Full Text] [Related]
17. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
18. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance.
Philpotts LE; Shaheen NA; Jain KS; Carter D; Lee CH
Radiology; 2000 Sep; 216(3):831-7. PubMed ID: 10966718
[TBL] [Abstract][Full Text] [Related]
19. [Papillary lesions of the breast: diagnostic imaging and contribution of percutaneous needle biopsy with 14G needle].
Bazzocchi M; Berra I; Francescutti GE; Del Frate C; Zuiani C; Puglisi F; Di Loreto C
Radiol Med; 2001 Jun; 101(6):424-31. PubMed ID: 11479438
[TBL] [Abstract][Full Text] [Related]
20. Management of papillary lesions of the breast: can larger core needle biopsy samples identify patients who may avoid surgical excision?
Shamonki J; Chung A; Huynh KT; Sim MS; Kinnaird M; Giuliano A
Ann Surg Oncol; 2013 Dec; 20(13):4137-44. PubMed ID: 23943035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
